Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

ESG Investment Europe

On Tuesday, 03 November 2020, Damiano de Felice, Director of Strategy at the Access to Medicine Foundation, will join Reuters' virtual ESG Investment Europe conference to discuss the challenges and solutions of using and creating reliable ESG data.

Date

03 November 2020

The ESG Investment Europe 2020 conference is a summit where European investment professionals can learn from their peers about ESG integration strategies. The two-day event will feature 30+ leading executive speakers, eight-panel sessions, six presentations and six exclusive 1-1 interview led by Reuters News. 

Damiano de Felice will participate in the panel "Overcome the Incomparability of ESG Data Sets: Useable Data to Drive Decision-Making" as a part of the day's overarching Regulation and ESG Drivers theme. In his remarks, Damiano will discuss:

  • How the Access to Medicine Foundation creates ESG data 

  • The challenges in creating reputable and reliable ESG data for investors

  • How investors in pharmaceutical companies can make better use of ESG data

The panel will be moderated by Pedro Fernandez, Head of Sustainability, responsAbility Investments AG. Other speakers on the panel include:

  • Lupin Rahman, Head of EM Sovereign Credit, PIMCO

  • Justin Kew, ESG Analyst, Carmignac

  • Dimitri Kyriakou, Senior Content and Technology Specialist, Europe, FACTSET

The full agenda for ESG Investment Europe 2020 can be found here.

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved